Entity
Obesity
Obesity is a medical condition characterized by excessive body fat accumulation that poses health risks. It is a significant public health concern and a focus area for pharmaceutical development of weight-loss drugs.
Why it’s in the news: It is in the news due to developments in obesity drug treatments, clinical trial results, and new health guidelines.
Latest on Obesity
- STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more
- STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
- STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
- STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
- Most powerful obesity drug yet: People lost up to 25% of weight in trial
- STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
Connections
2 entities linked to Obesity across the news graph.